1-4 of 4
cyclic phosphodiesterase, type 2
Close
Sort by
Journal Articles

Adenosine Regulation of cAMP through Phosphodiesterases

Bunyan Teng, PhD, Daniel N Darlington, PhD, Andrew P Cap, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2424.
https://doi.org/10.1182/blood-2018-99-114929
Published: 2018
Journal Articles

Adenosine A2A Receptor Agonism and PDE Inhibition: A Synergistic Multi-Target Mechanism Discovered through Systematic Combination Screening in Multiple Myeloma

Richard J Rickles, Ph.D., Laura Pierce, Thomas Giordano, Winnie F. Tam, Ph.D., Douglas W. McMillin, BSc, PhD, Kenneth C. Anderson, MD, Constantine Mitsiades, M.D., Ph.D., Margaret S Lee, Ph.D
Journal: Blood
Blood (2008) 112 (11): 847.
https://doi.org/10.1182/blood.V112.11.847.847
Published: 2008
Journal Articles

A Role of Autotaxin in Non-Mutational Resistance in Imatinib-Resistant Acute Lymphoblastic Leukemia (ALL) Cell Line SupB15 RT .

Aline Schmidt-Tanguy, MD, Annette Romanski, PhD, Patricia Mambou, PhD, Wolf-Karsten Hofmann, MD, Norbert Ifrah, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2007) 110 (11): 2804.
https://doi.org/10.1182/blood.V110.11.2804.2804
Published: 2007
Journal Articles

Tumor necrosis factor-α–dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability

Joachim Seybold, Dirk Thomas, Martin Witzenrath, Şengül Boral, Andreas C. Hocke, Alexander Bürger, Armin Hatzelmann, Hermann Tenor, Christian Schudt, Matthias Krüll, Hartwig Schütte, Stefan Hippenstiel, Norbert Suttorp
Journal: Blood
Blood (2005) 105 (9): 3569–3576.
https://doi.org/10.1182/blood-2004-07-2729
Published: 2005